KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Change in Accured Expenses (2016 - 2026)

Chemed filings provide 18 years of Change in Accured Expenses readings, the most recent being $6.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses rose 605.47% year-over-year to $6.7 million, compared with a TTM value of $16.2 million through Mar 2026, up 56.08%, and an annual FY2025 reading of $10.4 million, down 54.18% over the prior year.
  • Change in Accured Expenses hit $6.7 million in Q1 2026 for Chemed, up from $4.1 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $13.3 million in Q1 2024, with the low at -$5.1 million in Q3 2022.
  • Median Change in Accured Expenses over the past 5 years was $3.0 million (2022), compared with a mean of $2.9 million.
  • The sharpest move saw Change in Accured Expenses crashed 249.56% in 2022, then skyrocketed 605.47% in 2026.
  • Year by year, Change in Accured Expenses stood at $3.2 million in 2022, then plummeted by 57.07% to $1.4 million in 2023, then skyrocketed by 219.84% to $4.4 million in 2024, then dropped by 7.54% to $4.1 million in 2025, then skyrocketed by 64.88% to $6.7 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $6.7 million, $4.1 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.